New York Assembly Bill A10060

New York 2025-2026 Regular Session

• Introduced: 1/30/26
• Refer: 1/30/26

Caption

Authorizes high schools to include opioid overdose prevention and non-intravenous opioid antagonist administration as optional part of required health education courses; authorizes certain students to administer non-intravenous opioid antagonists.

Impact

If enacted, A10060 would amend existing education law to formally integrate opioid-related health education into high school curricula. The bill stipulates that students who receive proper training and parental consent will be allowed to carry and potentially administer life-saving treatments during school hours. This adds a vital layer to both students' health education and their capacity to act in emergencies, fostering a more informed and responsive school environment concerning opioid use and its dangers. Schools will also be mandated to develop instructional programs that ensure students can demonstrate proficiency in the use of these medications.

Summary

Bill A10060 aims to enhance health education in New York schools by incorporating opioid overdose prevention and training on the administration of non-intravenous opioid antagonists, such as naloxone. The bill permits high schools to include this training as an optional part of their required health courses and allows certain students to possess and administer these life-saving medications in emergency situations. This legislative initiative arises from the ongoing opioid crisis, emphasizing the necessity for proactive measures in educational settings to equip young individuals with the skills to respond to overdose incidents.

Contention

The bill has generated discussions around several points of contention, particularly concerning safety and liability. Supporters argue that by equipping students with the knowledge and tools to address opioid overdoses, the bill can positively impact health outcomes in schools and communities. Conversely, opponents raise concerns regarding the appropriateness of allowing students to administer medication without the immediate oversight of medical professionals. Additionally, there are worries about liability and the risk of misuse of these substances. Policymakers must carefully consider these dynamics to ensure that the implementation of A10060 promotes safe and effective educational practices.